How Lucky We Really Are: The Global Snakebite Crisis and Why Australia Is Different

A study released this year in PLOS Medicine has put a number on something that's been difficult to measure until now: the true scale of snakebite as a global public health crisis. Between 2.1 and 7 million people are envenomed by snakes each year. Between 274,000 and 513,000 die.

To give that context: that's more deaths annually than malaria or dengue fever causes in many parts of the world. Yet snakebite remains drastically underfunded and largely invisible to the people who need to care about it.

The data shows where the burden falls hardest. Sub Saharan Africa accounts for 45 percent of global envenomings and deaths. Low income countries, where rural communities live closest to snake habitat and where access to antivenom and medical care is severely limited, show the highest incidence and mortality rates.

Australia is a very different story.

We have dangerous snakes. Browns, tiger snakes, taipans, king browns. All of them demand respect. A bite from any of them can be serious. The difference is what happens next.

In Australia, a snakebite is a medical emergency that gets handled effectively. You call an ambulance. A trained paramedic arrives. You get to a hospital with staff who know how to manage envenoming. The right antivenom is available. Intensive care is available if needed. Most people recover.

In rural parts of sub Saharan Africa or south Asia, a snakebite often becomes a tragedy. Not because treatment is impossible, but because the treatment isn't available. A clinic might have no antivenom stockpile, or outdated stock, or the wrong type. A patient might die not from the bite itself but from the absence of the thing that could save them.

The research team identified three critical gaps in the regions where snakebite burden is highest. Prevention, antivenom access, and clinical care. Prevention means better housing, protective footwear, education about snake awareness, and modified work practices in places where people live close to snakes. Antivenom access means having the right stock available when it's needed. Clinical care means having trained staff who recognise envenoming, understand how to use antivenom, and can handle complications.

All three are absent or barely present in many of the places where snakebite kills most people.

What I've come to understand through my work catching snakes here is that we've been fortunate. Our health system works. Antivenom production and distribution is reliable. Public awareness of snakes is reasonable. We catch snakes and relocate them. We don't routinely kill them or panic when one appears. That's partly because we have the literacy and resources to handle the situation calmly.

That's not true everywhere. In regions where snakebite burden is highest, the response is often fear and violence. Snakes get killed indiscriminately. People take poorly informed risks. Myths about treatment delay proper medical care. A child might die because someone chose a folk remedy over hospital care.

The study calls for better prevention, improved surveillance, wider access to antivenom, and strengthened clinical care in the most affected regions. It's the right call. But it requires sustained funding and political will that hasn't materialised at the scale needed.

What this research does is give us the baseline. Now we know the true scale of the problem.

From where I sit, that's a reason to understand what we have here in Australia differently. When we respond to a snake with respect rather than panic, when we call a professional rather than reaching for a shovel, when we get to a hospital rather than trying a home remedy, we're benefiting from systems and knowledge that save lives. Most of the world doesn't have those systems.

That doesn't make Australian snakes less dangerous. It makes us less likely to die from them. And it says something about what's possible when prevention, access, and care are actually in place.